glutathione and multiple myeloma Intracellular determines bortezomib cytotoxicity in cells A myeloma-targeting monoclonal antibody offers
A myeloma targeting monoclonal antibody offers new hope for treating multiple myeloma EurekAlert! Frontiers Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance A recent editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros and Aiolos, to treat multiple myeloma. Panel A shows the chemical structures
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

